Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(8 sites)
China
Department of Endocrinology, Xiangya Hospital of Central South University, Changsha, Hunan
Department of Endocrinology, Changzhou No.2 People's Hospital, Changzhou, Jiangsu
Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu
Department of Endocrinology, Endocrine and Metabolic Disease Medical Center,Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu
Department of Endocrinology, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu
The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning
Department of Endocrinology, Shanghai General Hospital, Shanghai, Shanghai Municipality
Department of Endocrinology, Huadong Hospital Affiliated to Fudan University, Shanghai